Genesee Valley Trust Co. boosted its stake in Stericycle Inc. (NASDAQ:SRCL) by 1.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,511 shares of the company’s stock after buying an additional 43 shares during the period. Genesee Valley Trust Co.’s holdings in Stericycle were worth $470,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Jana Partners LLC purchased a new position in Stericycle during the first quarter valued at $305,997,000. Swedbank bought a new position in shares of Stericycle during the second quarter worth approximately $104,155,000. USS Investment Management Ltd bought a new position in shares of Stericycle during the first quarter worth approximately $80,866,000. Norges Bank bought a new position in shares of Stericycle during the fourth quarter worth approximately $76,432,000. Finally, NN Investment Partners Holdings N.V. bought a new position in shares of Stericycle during the first quarter worth approximately $56,798,000. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Shares of Stericycle Inc. (NASDAQ:SRCL) traded up 1.29% during mid-day trading on Wednesday, hitting $78.00. 1,254,100 shares of the stock were exchanged. The firm has a 50-day moving average price of $84.48 and a 200 day moving average price of $102.42. Stericycle Inc. has a 12-month low of $76.76 and a 12-month high of $151.57. The company has a market capitalization of $6.63 billion, a PE ratio of 27.46 and a beta of 0.27.

Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.18. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The business earned $891.60 million during the quarter, compared to analysts’ expectations of $910.29 million. During the same period in the prior year, the business earned $1.14 EPS. Stericycle’s revenue for the quarter was up 24.6% compared to the same quarter last year. On average, equities research analysts expect that Stericycle Inc. will post $4.67 earnings per share for the current year.

A number of brokerages recently commented on SRCL. Macquarie began coverage on shares of Stericycle in a research report on Thursday, August 25th. They set a “neutral” rating and a $96.00 price objective on the stock. Jefferies Group reaffirmed a “buy” rating and set a $112.50 price objective (down from $125.00) on shares of Stericycle in a research report on Wednesday, September 7th. Zacks Investment Research raised shares of Stericycle from a “sell” rating to a “hold” rating in a research report on Monday, July 4th. Imperial Capital downgraded shares of Stericycle from an “in-line” rating to an “underperform” rating and lowered their price objective for the company from $100.00 to $93.50 in a research report on Friday, July 29th. Finally, Wellington Shields downgraded shares of Stericycle from an “accumulate” rating to a “hold” rating in a research report on Friday, July 29th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $110.32.

In related news, EVP John P. Schetz sold 1,398 shares of the stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total transaction of $114,426.30. Following the completion of the sale, the executive vice president now directly owns 1,088 shares of the company’s stock, valued at approximately $89,052.80. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Rodney F. Dammeyer sold 10,188 shares of the stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total value of $871,074.00. Following the sale, the director now directly owns 10,188 shares of the company’s stock, valued at $871,074. The disclosure for this sale can be found here. Corporate insiders own 3.30% of the company’s stock.

About Stericycle

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.